Literature DB >> 22923731

Matrix control of transforming growth factor-β function.

Masahito Horiguchi1, Mitsuhiko Ota, Daniel B Rifkin.   

Abstract

The cytokine transforming growth factor-beta (TGF-β) has multiple effects in both physiological and pathological conditions. TGF-β is secreted as part of a tripartite complex from which it must be released in order to bind to its receptor. Sequestration of latent TGF-β in the extracellular matrix (ECM) is crucial for proper mobilization of the latent cytokine and its activation. However, contrary to expectation, loss-of-function mutations in genes encoding certain matrix proteins that bind TGF-β yield elevated, rather than decreased, TGF-β levels, posing a 'TGF-β paradox.' In this review, we discuss recent findings concerning the relationship of TGF-β, ECM molecules, and latent TGF-β activation and propose a model to resolve the 'TGF-β paradox.'

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22923731      PMCID: PMC3529568          DOI: 10.1093/jb/mvs089

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  81 in total

Review 1.  Latent transforming growth factor-beta (TGF-beta) binding proteins: orchestrators of TGF-beta availability.

Authors:  Daniel B Rifkin
Journal:  J Biol Chem       Date:  2004-12-16       Impact factor: 5.157

2.  Lung alveolar septation defects in Ltbp-3-null mice.

Authors:  Cristina Colarossi; Yan Chen; Hiroto Obata; Vladimir Jurukovski; Laura Fontana; Branka Dabovic; Daniel B Rifkin
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

3.  Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts.

Authors:  Yoshihde Asano; Hironobu Ihn; Kenichi Yamane; Masatoshi Jinnin; Yoshihiro Mimura; Kunihiko Tamaki
Journal:  Arthritis Rheum       Date:  2005-09

4.  Fibronectin regulates latent transforming growth factor-beta (TGF beta) by controlling matrix assembly of latent TGF beta-binding protein-1.

Authors:  Sarah L Dallas; Pitchumani Sivakumar; Carolyn J P Jones; Qian Chen; Donna M Peters; Deane F Mosher; Martin J Humphries; Cay M Kielty
Journal:  J Biol Chem       Date:  2005-01-27       Impact factor: 5.157

5.  Fibronectin is required for integrin alphavbeta6-mediated activation of latent TGF-beta complexes containing LTBP-1.

Authors:  Laura Fontana; Yan Chen; Petra Prijatelj; Takao Sakai; Reinhard Fässler; Lynn Y Sakai; Daniel B Rifkin
Journal:  FASEB J       Date:  2005-11       Impact factor: 5.191

6.  The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis.

Authors:  J S Munger; X Huang; H Kawakatsu; M J Griffiths; S L Dalton; J Wu; J F Pittet; N Kaminski; C Garat; M A Matthay; D B Rifkin; D Sheppard
Journal:  Cell       Date:  1999-02-05       Impact factor: 41.582

7.  An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis.

Authors:  Hideki Kizawa; Ikuyo Kou; Aritoshi Iida; Akihiro Sudo; Yoshinari Miyamoto; Akira Fukuda; Akihiko Mabuchi; Akihiro Kotani; Akira Kawakami; Seizo Yamamoto; Atsumasa Uchida; Kozo Nakamura; Kohei Notoya; Yusuke Nakamura; Shiro Ikegawa
Journal:  Nat Genet       Date:  2005-01-09       Impact factor: 38.330

8.  Interactions between growth factors and integrins: latent forms of transforming growth factor-beta are ligands for the integrin alphavbeta1.

Authors:  J S Munger; J G Harpel; F G Giancotti; D B Rifkin
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

Review 9.  TGF-beta signal transduction.

Authors:  J Massagué
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

10.  TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome.

Authors:  Connie M Ng; Alan Cheng; Loretha A Myers; Francisco Martinez-Murillo; Chunfa Jie; Djahida Bedja; Kathleen L Gabrielson; Jennifer M W Hausladen; Robert P Mecham; Daniel P Judge; Harry C Dietz
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

View more
  117 in total

Review 1.  Tendon development and musculoskeletal assembly: emerging roles for the extracellular matrix.

Authors:  Arul Subramanian; Thomas F Schilling
Journal:  Development       Date:  2015-12-15       Impact factor: 6.868

2.  Fibronectin regulates growth factor signaling and cell differentiation in primary lens cells.

Authors:  Judy K VanSlyke; Bruce A Boswell; Linda S Musil
Journal:  J Cell Sci       Date:  2018-11-20       Impact factor: 5.285

3.  Sensitization of transforming growth factor-β signaling by multiple peptides patterned on DNA nanostructures.

Authors:  Ronnie O Pedersen; Elizabeth G Loboa; Thomas H LaBean
Journal:  Biomacromolecules       Date:  2013-11-08       Impact factor: 6.988

4.  Elevated transforming growth factor β1 in plasma of primary open-angle glaucoma patients.

Authors:  John Kuchtey; Jessica Kunkel; L Goodwin Burgess; Megan B Parks; Milam A Brantley; Rachel W Kuchtey
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-24       Impact factor: 4.799

5.  Transforming growth factor-β2 is sequestered in preterm human milk by chondroitin sulfate proteoglycans.

Authors:  Kopperuncholan Namachivayam; Hayley P Coffing; Nehru Viji Sankaranarayanan; Yingzi Jin; Krishnan MohanKumar; Brandy L Frost; Cynthia L Blanco; Aloka L Patel; Paula P Meier; Steven A Garzon; Umesh R Desai; Akhil Maheshwari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-06-04       Impact factor: 4.052

6.  Intrinsic cardiomyopathy in Marfan syndrome: results from in-vivo and ex-vivo studies of the Fbn1C1039G/+ model and longitudinal findings in humans.

Authors:  Laurence Campens; Marjolijn Renard; Bram Trachet; Patrick Segers; Laura Muino Mosquera; Johan De Sutter; Lynn Sakai; Anne De Paepe; Julie De Backer
Journal:  Pediatr Res       Date:  2015-06-04       Impact factor: 3.756

7.  Integrins αvβ5 and αvβ3 promote latent TGF-β1 activation by human cardiac fibroblast contraction.

Authors:  Vincent Sarrazy; Anne Koehler; Melissa L Chow; Elena Zimina; Chen X Li; Hideyuki Kato; Christopher A Caldarone; Boris Hinz
Journal:  Cardiovasc Res       Date:  2014-03-17       Impact factor: 10.787

8.  Recombinant disintegrin targets α(v) β(3) integrin and leads to mediator production.

Authors:  Lívia C A Ribeiro; Lívia C Massimino; Araceli C Durante; Aline Tansini; Ana C Urbaczek; Heloísa S Selistre-de-Araújo; Iracilda Z Carlos
Journal:  Cell Adh Migr       Date:  2013-01-01       Impact factor: 3.405

9.  Identifying Mechanisms of Homeostatic Signaling in Fibroblast Differentiation.

Authors:  Hayley C Warsinske; Shanna L Ashley; Jennifer J Linderman; Bethany B Moore; Denise E Kirschner
Journal:  Bull Math Biol       Date:  2015-09-18       Impact factor: 1.758

Review 10.  The microfibril hypothesis of glaucoma: implications for treatment of elevated intraocular pressure.

Authors:  John Kuchtey; Rachel W Kuchtey
Journal:  J Ocul Pharmacol Ther       Date:  2014-02-12       Impact factor: 2.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.